These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24103541)

  • 1. Why do we need nongenomic glucocorticoid mechanisms?
    Jiang CL; Liu L; Tasker JG
    Front Neuroendocrinol; 2014 Jan; 35(1):72-5. PubMed ID: 24103541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological significance of nongenomic mechanisms of glucocorticoids].
    Liu L; Zhang T; Jiang CL
    Sheng Li Ke Xue Jin Zhan; 2013 Oct; 44(5):329-32. PubMed ID: 24475718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-genomic effect of glucocorticoids on cardiovascular system.
    Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J
    Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nongenomic glucocorticoid effects and their mechanisms of action in vertebrates.
    Johnstone WM; Honeycutt JL; Deck CA; Borski RJ
    Int Rev Cell Mol Biol; 2019; 346():51-96. PubMed ID: 31122395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nongenomic effects of glucocorticoids].
    Grzanka A; Jarzab J
    Pneumonol Alergol Pol; 2009; 77(4):387-93. PubMed ID: 19722144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel strategy of glucocorticoid drug development via targeting nongenomic mechanisms.
    Jiang CL; Liu L; Li Z; Buttgereit F
    Steroids; 2015 Oct; 102():27-31. PubMed ID: 26122209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
    Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
    FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-genomic Effects of Glucocorticoids: An Updated View.
    Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
    Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.
    Kharwanlang B; Sharma R
    Indian J Biochem Biophys; 2011 Aug; 48(4):236-42. PubMed ID: 22053692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid.
    Chen YZ; Qiu J
    Mol Cell Biol Res Commun; 1999; 2(3):145-9. PubMed ID: 10662589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional and nongenomic effects of glucocorticoids.
    Stellato C
    Proc Am Thorac Soc; 2004; 1(3):255-63. PubMed ID: 16113443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic.
    Marchi D; van Eeden FJM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5α-Reduced glucocorticoids: a story of natural selection.
    Nixon M; Upreti R; Andrew R
    J Endocrinol; 2012 Feb; 212(2):111-27. PubMed ID: 21903862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel aspects of glucocorticoid actions.
    Uchoa ET; Aguilera G; Herman JP; Fiedler JL; Deak T; de Sousa MB
    J Neuroendocrinol; 2014 Sep; 26(9):557-72. PubMed ID: 24724595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.